← Back
$INDV All transactions

Indivior Pharmaceuticals, Inc.

A

$ Value

$0

Shares

104,300

Price

$0

Filed

Feb 12

Insider

Name

Burris Jeffrey W

Title

Chief Legal Officer

CIK

0001484322

Roles

Officer

Transaction Details

Transaction Date

2026-02-09

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

104,300

Footnotes

Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer. | On March 3, 2023, the Reporting Person was granted a conditional award for 104,300 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026.

Filing Info

Accession No.

0001484322-26-000011

Form Type

4

Issuer CIK

0001625297

Burris Jeffrey W's History

Date Ticker Type Value
2026-03-03 INDV M
2026-03-03 INDV F $1.2M
2026-03-03 INDV M
2026-02-10 INDV A $0
2026-02-09 INDV A $0

Other Insiders at INDV (90d)

Insider Bought Sold Last
Kingsley Stuart A $30K 2026-03-06
Ryan Barbara $1K 2026-03-13
NINIVAGGI DANIEL A 2026-01-26
Ciaffoni Joseph
Chief Executive Officer
2026-02-10
Burris Jeffrey W
Chief Legal Officer
2026-03-03
Stejbach Mark 2026-01-26
Thompson Juliet 2026-01-26
Barry Patrick A
Chief Commercial Officer
2026-02-10
Wheadon David E. 2026-01-26
Anderson Woodrow D
Chief Accounting Officer
2026-03-03
Heidbreder Christian
Chief Scientific Officer
2026-03-03
Preblick Ryan
Chief Financial Officer
2026-03-14
Humphreys Keith 2026-01-26